Cranbrook Wealth Management, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cranbrook Wealth Management, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$20,313
-1.5%
1,3130.0%0.01%0.0%
Q2 2023$20,628
-4.7%
1,3130.0%0.01%0.0%
Q1 2023$21,639
+5.6%
1,3130.0%0.01%0.0%
Q4 2022$20,483
+20.5%
1,3130.0%0.01%
+50.0%
Q3 2022$17,000
-5.6%
1,3130.0%0.00%
-20.0%
Q2 2022$18,000
-5.3%
1,3130.0%0.01%
+25.0%
Q1 2022$19,000
+5.6%
1,3130.0%0.00%0.0%
Q4 2021$18,000
-18.2%
1,3130.0%0.00%
-20.0%
Q3 2021$22,0000.0%1,3130.0%0.01%0.0%
Q2 2021$22,000
-8.3%
1,3130.0%0.01%
-16.7%
Q1 2021$24,0000.0%1,3130.0%0.01%0.0%
Q4 2020$24,000
+4.3%
1,3130.0%0.01%
-14.3%
Q3 2020$23,000
-4.2%
1,3130.0%0.01%0.0%
Q2 2020$24,000
+20.0%
1,3130.0%0.01%0.0%
Q1 2020$20,000
-23.1%
1,3130.0%0.01%0.0%
Q4 2019$26,000
+13.0%
1,3130.0%0.01%0.0%
Q3 2019$23,0000.0%1,3130.0%0.01%0.0%
Q2 2019$23,000
-14.8%
1,3130.0%0.01%
-12.5%
Q1 2019$27,0001,3130.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders